Globally available and approved HPV vaccines, although successful, are still expensive in LMICs. Therefore, India has been putting efforts into a locally produced HPV vaccine. The affordability of this vaccine makes the impact potentially transformative, but its future success depends on scaling up and utilizing effective strategies for nationwide implementation.
Venghateri et al. (Tue,) studied this question.